GlassScriptPhysician profile
Cooper Randall Trost
NPI 1740846989
$5,019.07
in general payments reported to CMS, 2019-2025
23 companies · $524 in 2025
The $524 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.29 · 2020: $16.83 · 2022: $666 · 2023: $426 · 2024: $3,339 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,289.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2024 | |
| Gynesonics, INC. | $335.46 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $189.79 | 2022-2025 | Liletta |
| Hologic Sales and Service, LLC | $175.82 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Coloplast Corp | $171.17 | 2022 | |
| Organon LLC | $164.63 | 2024-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $126.80 | 2023 | Myfembree |
| Baxter Healthcare | $121.84 | 2022 | |
| Pfizer INC. | $114.14 | 2024-2025 | |
| Femselect INC. | $96.88 | 2023 | Enplace |
| Mayne Pharma Commercial LLC | $93.41 | 2022-2025 | |
| Shield Therapeutics INC | $91.16 | 2024-2025 | |
| Dexcom, INC. | $88.49 | 2023-2025 | Dexcom G6 Transmitter |
| Exeltis, USA INC. | $85.98 | 2024-2025 | Slynd |
| Agile Therapeutics, INC. | $33.16 | 2024 | Twirla |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $24.61 | 2025 | Intrarosa, Femlyv |
| Smith+Nephew, INC. | $17.00 | 2024 | Pico 14 |
| Medtronic, INC. | $16.99 | 2025 | Ligasure |
| Coopersurgical, INC. | $16.59 | 2023 | Mara Console |
| Pacira Pharmaceuticals Incorporated | $16.59 | 2019 | |
| Sage Therapeutics, LLC | $14.91 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $14.91 | 2025 | Qelbree |
| Mission Pharmacal Company | $8.74 | 2023-2024 | Citranatal Medley |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cooper Trost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.